ImmunityBio stock jumps 35% as ANKTIVA bladder cancer trial update puts FDA filing in view

ImmunityBio stock jumps 35% as ANKTIVA bladder cancer trial update puts FDA filing in view

ImmunityBio shares surged 35% Friday after reporting faster enrollment and positive interim results in its ANKTIVA bladder cancer trial. The company also disclosed $113 million in 2025 preliminary revenue and Saudi approval for ANKTIVA in lung cancer. Shares traded at $5.34 by midday with 133 million shares changing hands. Early data from its CD19 CAR-NK cell therapy showed complete responses in Waldenström lymphoma.
BMNR stock edges up as BitMine’s $200 million MrBeast bet collides with dilution worries

BMNR stock edges up as BitMine’s $200 million MrBeast bet collides with dilution worries

BitMine Immersion Technologies shares rose 0.2% to $30.93 by 1 p.m. EST Friday after the company announced a $200 million investment in MrBeast’s Beast Industries, with deal closing expected Jan. 19. B. Riley reiterated a Buy rating and $47 target. Investors watched for fallout from a proposed share authorization increase to 50 billion. Ether and bitcoin prices slipped, weighing on crypto-linked stocks.
16 January 2026
Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings

Intuitive Surgical stock slips again as 2026 da Vinci outlook hangs over ISRG ahead of earnings

Intuitive Surgical shares fell 0.9% to $536.49 in early New York trading Friday after the company’s 2026 da Vinci procedure-growth forecast missed some investor expectations. The company reported unaudited Q4 revenue of $2.87 billion, up 19%, and projected 2026 da Vinci procedure growth of 13% to 15%. Investors await more detail at the Jan. 22 earnings call.
GE Vernova stock jumps 6% as Trump-backed PJM power auction plan targets AI data-center demand

GE Vernova stock jumps 6% as Trump-backed PJM power auction plan targets AI data-center demand

GE Vernova shares surged 6.1% to $681.57 after the White House and PJM state governors proposed a $15 billion emergency auction to boost power supply for AI data centers. Constellation Energy, Vistra, and Talen Energy stocks fell sharply as investors weighed the impact of accelerated generation on prices. PJM and regulators are set to provide updates before GE Vernova’s Jan. 28 earnings.
IonQ stock jumps nearly 8% as quantum IPO chatter returns; traders eye next catalyst

IonQ stock jumps nearly 8% as quantum IPO chatter returns; traders eye next catalyst

IonQ shares rose 7.7% to $51.24 by early Friday afternoon, outpacing other tech stocks after reports that Quantinuum may pursue an IPO. The rally followed news that Katie Arrington will become IonQ’s chief information officer Jan. 19, while Leslie Kershaw takes on an expanded security role. IonQ’s next earnings report is expected in late February.
Morgan Stanley stock climbs after earnings beat — deal pipeline and Fed are the next tests

Morgan Stanley stock climbs after earnings beat — deal pipeline and Fed are the next tests

Morgan Stanley shares rose 0.6% to $192.40 midday Friday after quarterly earnings beat forecasts, with investment banking revenue up 47% to $2.41 billion. The bank posted $2.68 per share, surpassing the $2.44 LSEG consensus, and reported $17.89 billion in net revenue and $4.40 billion in net income for the quarter. Wealth Management revenue reached $8.43 billion. The firm announced a $1.00 dividend, payable Feb. 13.
Talen Energy stock swings after $3.45 billion gas-plant deal — what TLN traders are watching

Talen Energy stock swings after $3.45 billion gas-plant deal — what TLN traders are watching

Talen Energy shares dropped 7.7% to $386.67 in midday New York trading Friday, erasing gains from the previous session. The decline followed Talen’s $3.45 billion deal to buy three gas plants from Energy Capital Partners, funded with $2.55 billion in cash, $900 million in stock, and new debt. Investors focused on dilution, debt details, and a possible new data-center contract.
16 January 2026
Nebius stock rises as Morgan Stanley starts coverage and ClickHouse funding puts stakes back in focus

Nebius stock rises as Morgan Stanley starts coverage and ClickHouse funding puts stakes back in focus

Nebius Group shares rose 3.9% to $107.89 by midday Friday after Morgan Stanley initiated coverage with an equal-weight rating and a $126 target, according to sources. The move followed ClickHouse’s announcement of a $15 billion valuation and $400 million funding round; Nebius holds an equity stake in ClickHouse. Nearly 9.8 million Nebius shares traded as the stock swung between $100.80 and $110.47.
16 January 2026

Stock Market Today

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

Broadcom Stock Gets a Google AI Spend Lift as Jefferies Sees 60% Upside

7 February 2026
Google raised its 2026 capital expenditure forecast to $175 billion–$185 billion, with most spending expected on data-center chips. Broadcom shares rose about 2% after the announcement, while Nvidia and AMD slipped. Jefferies reiterated a buy rating on Broadcom, maintaining a $500 price target, implying a 62% upside from Wednesday’s close.
No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

No $2,000 IRS stimulus check is coming in February 2026 — but Trump’s tariff-check talk keeps the rumors alive

7 February 2026
The IRS has not announced new federal stimulus payments for February 2026, and Congress has not approved fresh checks. Trump told NBC he is considering $2,000 tariff rebate checks but has not committed, saying any payout would likely come later in 2026. The IRS warns taxpayers to ignore texts and emails about “stimulus payments” and verify notices through official channels.
Go toTop